|
|
|
European Biopharmaceutical Review
|
| Mary Harney is the Irish Deputy Prime Minister and Minister for Enterprise Trade and Employment. She has had a direct hand in driving Ireland's recent impressive science research foundation programmes, identified as critical if Ireland was to underpin an emerging biotechnology industry on the back of decades of inward investment in pharmaceutical manufacturing expertise. A Tainiste, to give Mrs Harney her true political title in Ireland, is equally outspoken on the importance of knowledge-based industry - and biotechnology in particular - to future European economic growth along with the need for political will to replace rhetoric at the highest level. As incoming President of the EU Competitiveness Council, which oversees the EU's life sciences biotechnology strategy, Mrs Harney represented the most relevant and senior of political commentators to bring the political message at the Opening Plenary session of the CORDIA-EuropaBio Convention in December 2003. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
3rd African Regulatory Conference (ARC)
3-4 May 2012, Accra, Ghana
The African Regulatory Conference offers the opportunity for key stakeholders active on the continent, including representatives from Ministry of Health, local and multinational pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|
